Longeveron Inc. (LGVN) NASDAQ
$1.28 (0.01) (-0.78%)
Market Cap: $6.28M
As of 05/17/24 04:00 PM EDT. Market closed.
Longeveron Inc. (LGVN)
NASDAQ
$1.28
(0.01) (-0.78%)
Market Cap: $6.28M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
26
Address
.
PRICE CHART FOR LONGEVERON INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.30
Previous Close
$1.29
Days Range
$1.26 - $1.32
52 week range
$1.24 - $40
Volume
232,595
Avg. Volume (30 days)
449,144
Market Cap
$6.28M
Dividend Yield
-
P/E
(0.29)
Shares Outstanding
4,864,619
Open
$1.30
Previous Close
$1.29
Days Range
$1.26 - $1.32
52 week range
$1.24 - $40
Volume
232,595
Avg. Volume (30 days)
449,144
Market Cap
$6.28M
Dividend Yield
-
P/E
(0.29)
Shares Outstanding
4,864,619
FINANCIAL STATEMENTS FOR LONGEVERON INC
LOADING...
INSIDER TRANSACTIONS FOR LONGEVERON INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Kender Richard N | Director | May 10, 2024 | Option Exercise | $1.46 | 16,000 | 23,280 | 16,000 | May 14, 2024, 07:10 PM |
Locklear Lisa | Chief Financial Officer | May 02, 2024 | Option Exercise | $2.83 | 410 | 1,160 | 3,273 | May 06, 2024, 06:59 PM |
Agafonova Nataliya | Chief Medical Officer | May 02, 2024 | Option Exercise | $2.83 | 308 | 872 | 1,771 | May 06, 2024, 06:59 PM |
Hare Joshua | Chief Scientific Officer | Apr 11, 2024 | Buy | $2.35 | 42,553 | 100,000 | 633,280 | Apr 12, 2024, 07:00 PM |
Hare Joshua | Chief Scientific Officer | Apr 10, 2024 | Buy | $2.35 | 106,383 | 250,000 | 590,727 | Apr 12, 2024, 07:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 11, 2024 | Buy | $2.35 | 10,638 | 24,999 | 19,616 | Apr 12, 2024, 07:00 PM |
Soffer Rock | Director | Apr 11, 2024 | Buy | $2.35 | 31,915 | 75,000 | 208,534 | Apr 12, 2024, 07:00 PM |
Soffer Rock | Director | Apr 10, 2024 | Buy | $2.35 | 106,383 | 250,000 | 176,619 | Apr 12, 2024, 07:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Mar 12, 2024 | Option Exercise | $0.54 | 32,866 | 17,748 | 89,777 | Mar 20, 2024, 05:00 PM |
Locklear Lisa | Chief Financial Officer | Jan 02, 2024 | Option Exercise | $1.32 | 4,098 | 5,409 | 36,824 | Jan 25, 2024, 06:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Jan 02, 2024 | Option Exercise | $1.32 | 5,123 | 6,762 | 42,443 | Jan 25, 2024, 06:00 PM |
Lehr Paul T | General Counsel, Secretary | Jan 02, 2024 | Option Exercise | $1.32 | 992 | 1,309 | 142,406 | Jan 25, 2024, 06:00 PM |
Agafonova Nataliya | Chief Medical Officer | Jan 02, 2024 | Option Exercise | $1.32 | 3,074 | 4,058 | 20,786 | Jan 25, 2024, 06:00 PM |
Ross Cathy | Director | Jan 10, 2024 | Buy | $1.31 | 5,000 | 6,544 | 10,000 | Jan 11, 2024, 06:00 PM |
Baluch Khoso | Director | Dec 28, 2023 | Buy | $1.40 | 1,678 | 2,342 | 6,678 | Jan 02, 2024, 06:00 PM |
Baluch Khoso | Director | Dec 29, 2023 | Buy | $1.43 | 8,322 | 11,915 | 15,000 | Jan 02, 2024, 06:00 PM |
PFEFFER JEFFREY | Director | Dec 28, 2023 | Buy | $1.35 | 10,000 | 13,500 | 15,000 | Dec 29, 2023, 05:00 PM |
Lehr Paul T | General Counsel, Secretary | Oct 02, 2023 | Option Exercise | $2.29 | 815 | 1,866 | 143,398 | Oct 04, 2023, 05:00 PM |
Locklear Lisa | Chief Financial Officer | Oct 02, 2023 | Option Exercise | $2.29 | 4,078 | 9,339 | 40,922 | Oct 04, 2023, 05:00 PM |
Agafonova Nataliya | Chief Medical Officer | Oct 02, 2023 | Option Exercise | $2.29 | 3,059 | 7,005 | 23,860 | Oct 04, 2023, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Sep 21, 2023 | Option Exercise | $3.00 | 5,000 | 15,000 | 7,828,263 | Sep 22, 2023, 07:00 PM |
Lehr Paul T | General Counsel, Secretary | Sep 20, 2023 | Option Exercise | $3.00 | 2,000 | 6,000 | 144,213 | Sep 21, 2023, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Sep 12, 2023 | Option Exercise | $3.00 | 30,000 | 90,000 | 7,823,263 | Sep 14, 2023, 05:09 PM |
Locklear Lisa | Chief Financial Officer | Sep 12, 2023 | Option Exercise | $3.00 | 5,000 | 15,000 | 45,000 | Sep 13, 2023, 05:55 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sep 12, 2023 | Option Exercise | $3.00 | 10,000 | 30,000 | 47,566 | Sep 13, 2023, 05:00 PM |
Soffer Rock | Director | Sep 08, 2023 | Option Exercise | $3.00 | 30,000 | 90,000 | 702,351 | Sep 12, 2023, 05:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sep 01, 2023 | Option Exercise | $2.64 | 4,323 | 11,413 | 37,566 | Sep 06, 2023, 05:00 PM |
Lehr Paul T | General Counsel, Secretary | Aug 18, 2023 | Option Exercise | $3.25 | 767 | 2,493 | 142,213 | Aug 22, 2023, 05:00 PM |
Agafonova Nataliya | Chief Medical Officer | Aug 18, 2023 | Option Exercise | $3.36 | 3,081 | 10,352 | 26,919 | Aug 22, 2023, 05:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Aug 18, 2023 | Option Exercise | $3.25 | 4,292 | 13,949 | 41,889 | Aug 22, 2023, 05:00 PM |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 05, 2023 | Option Exercise | $2.61 | 3,819 | 9,968 | 46,181 | Jul 17, 2023, 05:48 PM |
Clavijo James | CFO and Treasurer | Jun 29, 2023 | Sale | $3.51 | 5,000 | 17,550 | 47,303 | Jun 29, 2023, 05:00 PM |
Clavijo James | CFO and Treasurer | Jun 28, 2023 | Sale | $3.43 | 10,000 | 34,300 | 52,303 | Jun 29, 2023, 05:00 PM |
Clavijo James | CFO and Treasurer | Jun 27, 2023 | Sale | $3.48 | 8,532 | 29,691 | 62,303 | Jun 29, 2023, 05:00 PM |
Clavijo James | CFO and Treasurer | Jun 02, 2023 | Option Exercise | $3.42 | 752 | 2,572 | 70,835 | Jun 12, 2023, 05:15 PM |
Lehr Paul T | General Counsel, Secretary | Jun 02, 2023 | Option Exercise | $3.25 | 3,247 | 10,553 | 142,980 | Jun 09, 2023, 05:00 PM |
Clavijo James | CFO and Treasurer | Jun 02, 2023 | Option Exercise | $3.25 | 3,247 | 10,553 | 71,587 | Jun 09, 2023, 05:00 PM |
Lehr Paul T | General Counsel, Secretary | Apr 03, 2023 | Option Exercise | $2.61 | 815 | 2,127 | 146,227 | Apr 05, 2023, 04:59 PM |
Clavijo James | CFO and Treasurer | Apr 03, 2023 | Option Exercise | $2.61 | 815 | 2,127 | 74,834 | Apr 05, 2023, 04:58 PM |
Hare Joshua | Chief Scientific Officer | Jan 27, 2023 | Sale | $4.28 | 20,000 | 85,600 | 7,793,263 | Jan 30, 2023, 05:00 PM |
Lehr Paul T | General Counsel, Secretary | Jan 03, 2023 | Option Exercise | $3.37 | 1,472 | 4,961 | 147,042 | Jan 04, 2023, 05:00 PM |
Clavijo James | CFO and Treasurer | Jan 03, 2023 | Option Exercise | $3.37 | 1,288 | 4,341 | 75,649 | Jan 04, 2023, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Dec 02, 2022 | Sale | $3.74 | 20,000 | 74,800 | 7,813,263 | Dec 05, 2022, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Oct 12, 2022 | Sale | $3.61 | 100,000 | 361,000 | 7,813,263 | Oct 18, 2022, 05:01 PM |
Clavijo James | CFO and Treasurer | Oct 03, 2022 | Option Exercise | $3.75 | 1,256 | 4,710 | 76,937 | Oct 05, 2022, 05:01 PM |
Lehr Paul T | General Counsel, Secretary | Oct 03, 2022 | Option Exercise | $3.75 | 1,435 | 5,381 | 148,514 | Oct 05, 2022, 05:00 PM |
Clavijo James | CFO and Treasurer | Jul 01, 2022 | Option Exercise | $5.94 | 1,426 | 8,470 | 78,193 | Jul 05, 2022, 05:01 PM |
Lehr Paul T | General Counsel, Secretary | Jul 01, 2022 | Option Exercise | $5.94 | 1,629 | 9,676 | 149,949 | Jul 05, 2022, 05:00 PM |
Clavijo James | CFO and Treasurer | Jun 03, 2022 | Sale | $8.26 | 36,955 | 305,248 | 79,619 | Jun 07, 2022, 05:00 PM |
Soffer Rock | Director | May 24, 2022 | Sale | $7.50 | 4,000 | 30,000 | 672,351 | May 24, 2022, 05:14 PM |
Soffer Rock | Director | May 23, 2022 | Sale | $7.78 | 8,000 | 62,200 | 676,351 | May 24, 2022, 05:14 PM |
Soffer Rock | Director | May 20, 2022 | Sale | $8.06 | 7,500 | 60,435 | 684,351 | May 24, 2022, 05:14 PM |
Hare Joshua | Chief Scientific Officer | Apr 19, 2022 | Sale | $10.00 | 78 | 780 | 7,913,263 | Apr 20, 2022, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Apr 18, 2022 | Sale | $10.00 | 19,922 | 199,290 | 7,913,341 | Apr 20, 2022, 05:00 PM |
Lehr Paul T | General Counsel, Secretary | Apr 04, 2022 | Option Exercise | $15.61 | 1,472 | 22,978 | 111,578 | Apr 08, 2022, 05:00 PM |
Green Geoff | CEO | Apr 04, 2022 | Option Exercise | $15.61 | 1,840 | 28,722 | 133,904 | Apr 08, 2022, 05:00 PM |
Hare Joshua | Chief Scientific Officer | Oct 12, 2021 | Buy | $3.69 | 2,500 | 9,225 | 7,933,263 | Oct 14, 2021, 09:00 AM |
Green Geoff | CEO | Oct 13, 2021 | Buy | $3.81 | 1,000 | 3,810 | 139,723 | Oct 14, 2021, 09:00 AM |
Soffer Rock | Director | Oct 11, 2021 | Buy | $3.45 | 3,900 | 13,455 | 35,757 | Oct 13, 2021, 06:00 PM |
Soffer Rock | Director | Oct 13, 2021 | Buy | $3.76 | 12,000 | 45,120 | 51,757 | Oct 13, 2021, 06:00 PM |
Soffer Rock | Director | Oct 12, 2021 | Buy | $3.57 | 4,000 | 14,280 | 39,757 | Oct 13, 2021, 06:00 PM |
Clavijo James | CFO and Treasurer | Oct 07, 2021 | Buy | $3.34 | 5,000 | 16,700 | 79,598 | Oct 12, 2021, 09:30 AM |
Lehr Paul T | General Counsel, Secretary | Oct 07, 2021 | Buy | $3.34 | 1,750 | 5,845 | 116,366 | Oct 12, 2021, 09:30 AM |
Hare Joshua | Chief Scientific Officer | Oct 08, 2021 | Buy | $3.39 | 3,015 | 10,221 | 7,930,763 | Oct 12, 2021, 09:30 AM |
Hare Joshua | Chief Scientific Officer | Oct 07, 2021 | Buy | $3.38 | 1,985 | 6,709 | 7,927,748 | Oct 12, 2021, 09:30 AM |
Lehr Paul T | General Counsel, Secretary | Oct 01, 2021 | Option Exercise | $3.65 | 38,752 | 141,445 | 114,616 | Oct 01, 2021, 08:01 PM |
Clavijo James | CFO and Treasurer | Oct 01, 2021 | Option Exercise | $3.65 | 19,052 | 69,540 | 74,598 | Oct 01, 2021, 08:00 PM |
Green Geoff | CEO | Oct 01, 2021 | Option Exercise | $3.65 | 43,929 | 160,341 | 138,723 | Oct 01, 2021, 08:00 PM |
Hare Joshua | Chief Scientific Officer | Feb 12, 2021 | Buy | $10.00 | 12,000 | 120,000 | 7,908,428 | Apr 09, 2021, 04:03 PM |
Soffer Rock | Director | Feb 12, 2021 | Buy | $8.05 | 100 | 805 | 26,857 | Feb 26, 2021, 06:00 PM |
Soffer Donald M | Director | Feb 12, 2021 | Buy | $10.00 | 100,000 | 1,000,000 | 153,514 | Feb 26, 2021, 06:00 PM |
Hare Joshua | Chief Scientific Officer | Feb 12, 2021 | Buy | $9.98 | 103,000 | 1,028,230 | 7,998,428 | Feb 17, 2021, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Kender Richard N | Director | 05/10/2024 | 23,280 |
Locklear Lisa | Chief Financial Officer | 05/02/2024 | 1,160 |
Agafonova Nataliya | Chief Medical Officer | 05/02/2024 | 872 |
Hare Joshua | Chief Scientific Officer | 04/11/2024 | 100,000 |
Hare Joshua | Chief Scientific Officer | 04/10/2024 | 250,000 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 04/11/2024 | 24,999 |
Soffer Rock | Director | 04/11/2024 | 75,000 |
Soffer Rock | Director | 04/10/2024 | 250,000 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 03/12/2024 | 17,748 |
Locklear Lisa | Chief Financial Officer | 01/02/2024 | 5,409 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 01/02/2024 | 6,762 |
Lehr Paul T | General Counsel, Secretary | 01/02/2024 | 1,309 |
Agafonova Nataliya | Chief Medical Officer | 01/02/2024 | 4,058 |
Ross Cathy | Director | 01/10/2024 | 6,544 |
Baluch Khoso | Director | 12/28/2023 | 2,342 |
Baluch Khoso | Director | 12/29/2023 | 11,915 |
PFEFFER JEFFREY | Director | 12/28/2023 | 13,500 |
Lehr Paul T | General Counsel, Secretary | 10/02/2023 | 1,866 |
Locklear Lisa | Chief Financial Officer | 10/02/2023 | 9,339 |
Agafonova Nataliya | Chief Medical Officer | 10/02/2023 | 7,005 |
Hare Joshua | Chief Scientific Officer | 09/21/2023 | 15,000 |
Lehr Paul T | General Counsel, Secretary | 09/20/2023 | 6,000 |
Hare Joshua | Chief Scientific Officer | 09/12/2023 | 90,000 |
Locklear Lisa | Chief Financial Officer | 09/12/2023 | 15,000 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 09/12/2023 | 30,000 |
Soffer Rock | Director | 09/08/2023 | 90,000 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 09/01/2023 | 11,413 |
Lehr Paul T | General Counsel, Secretary | 08/18/2023 | 2,493 |
Agafonova Nataliya | Chief Medical Officer | 08/18/2023 | 10,352 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 08/18/2023 | 13,949 |
Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 04/05/2023 | 9,968 |
Clavijo James | CFO and Treasurer | 06/29/2023 | 17,550 |
Clavijo James | CFO and Treasurer | 06/28/2023 | 34,300 |
Clavijo James | CFO and Treasurer | 06/27/2023 | 29,691 |
Clavijo James | CFO and Treasurer | 06/02/2023 | 2,572 |
Lehr Paul T | General Counsel, Secretary | 06/02/2023 | 10,553 |
Clavijo James | CFO and Treasurer | 06/02/2023 | 10,553 |
Lehr Paul T | General Counsel, Secretary | 04/03/2023 | 2,127 |
Clavijo James | CFO and Treasurer | 04/03/2023 | 2,127 |
Hare Joshua | Chief Scientific Officer | 01/27/2023 | 85,600 |
Lehr Paul T | General Counsel, Secretary | 01/03/2023 | 4,961 |
Clavijo James | CFO and Treasurer | 01/03/2023 | 4,341 |
Hare Joshua | Chief Scientific Officer | 12/02/2022 | 74,800 |
Hare Joshua | Chief Scientific Officer | 10/12/2022 | 361,000 |
Clavijo James | CFO and Treasurer | 10/03/2022 | 4,710 |
Lehr Paul T | General Counsel, Secretary | 10/03/2022 | 5,381 |
Clavijo James | CFO and Treasurer | 07/01/2022 | 8,470 |
Lehr Paul T | General Counsel, Secretary | 07/01/2022 | 9,676 |
Clavijo James | CFO and Treasurer | 06/03/2022 | 305,248 |
Soffer Rock | Director | 05/24/2022 | 30,000 |
Soffer Rock | Director | 05/23/2022 | 62,200 |
Soffer Rock | Director | 05/20/2022 | 60,435 |
Hare Joshua | Chief Scientific Officer | 04/19/2022 | 780 |
Hare Joshua | Chief Scientific Officer | 04/18/2022 | 199,290 |
Lehr Paul T | General Counsel, Secretary | 04/04/2022 | 22,978 |
Green Geoff | CEO | 04/04/2022 | 28,722 |
Hare Joshua | Chief Scientific Officer | 10/12/2021 | 9,225 |
Green Geoff | CEO | 10/13/2021 | 3,810 |
Soffer Rock | Director | 10/11/2021 | 13,455 |
Soffer Rock | Director | 10/13/2021 | 45,120 |
Soffer Rock | Director | 10/12/2021 | 14,280 |
Clavijo James | CFO and Treasurer | 10/07/2021 | 16,700 |
Lehr Paul T | General Counsel, Secretary | 10/07/2021 | 5,845 |
Hare Joshua | Chief Scientific Officer | 10/08/2021 | 10,221 |
Hare Joshua | Chief Scientific Officer | 10/07/2021 | 6,709 |
Lehr Paul T | General Counsel, Secretary | 10/01/2021 | 141,445 |
Clavijo James | CFO and Treasurer | 10/01/2021 | 69,540 |
Green Geoff | CEO | 10/01/2021 | 160,341 |
Hare Joshua | Chief Scientific Officer | 02/12/2021 | 120,000 |
Soffer Rock | Director | 02/12/2021 | 805 |
Soffer Donald M | Director | 02/12/2021 | 1,000,000 |
Hare Joshua | Chief Scientific Officer | 02/12/2021 | 1,028,230 |
Load More Insider Transactions
FUNDS WITH A POSITION IN LONGEVERON INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 111,700 | 0% | Exited | Other |
GEODE CAPITAL MANAGEMENT, LLC | 90,238 | 0.00001% | Exited | Other |
BLACKROCK INC. | 11,141 | 0% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR LONGEVERON INC
STOCK BUYBACKS FOR LONGEVERON INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
-88.04%
5Q
09/30/2022
-88.03%
6Q
06/30/2022
-88.00%
7Q
03/31/2022
-87.98%
8Q
12/31/2021
-87.45%
9Q
09/30/2021
-86.85%
10Q
06/30/2021
-86.77%
11Q
03/31/2021
-85.63%
12Q
12/31/2020
-84.33%
13Q
09/30/2020
-84.33%
14Q
06/30/2020
-84.26%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR LONGEVERON INC
LOADING...